Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 11/20 | 0.45 |
| ▸ | CA1 | P00915 | 9/20 | 0.45 |
| ▸ | CA9 | Q16790 | 8/20 | 0.45 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.45 |
| ▸ | MAOA | P21397 | 1/20 | 0.44 |
| ▸ | MAOB | P27338 | 1/20 | 0.44 |
| ▸ | CA12 | O43570 | 5/20 | 0.44 |
| ▸ | PTGS2 | P35354 | 4/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | HPGDS | O60760 | 1/20 | 0.42 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.41 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.40 |
| ▸ | IKBKB | O14920 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5822874 | 0.85 | PTGS2 (0.54) | CA2CA1CA9MAOAMAOB | |
| SCHEMBL4733933 | 0.79 | CA2 (0.61) | CA2CA1CA9CA13CA12 | |
| SCHEMBL30069032 | 0.79 | CA1 (0.57) | CA2CA1CA9CA13MAOA | |
| SCHEMBL18118203 | 0.79 | CA1 (0.57) | CA2CA1CA9CA13MAOA | |
| SCHEMBL7129733 | 0.78 | HPGDS (0.50) | HPGDS | |
| SCHEMBL8908994 | 0.78 | MAOB (0.47) | CA2CA1CA9MAOBCA12 | |
| SCHEMBL7408121 | 0.78 | HPGDS (0.44) | CA2CA1CA9CA13MAOA | |
| SCHEMBL30434205 | 0.77 | CA2 (0.64) | CA2CA1CA9CA13CA12 | |
| SCHEMBL9510279 | 0.76 | HPGDS (0.58) | HPGDS | |
| SCHEMBL942521 | 0.76 | HPGDS (0.47) | MAOBTDP1HPGDS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0825989-A1 | SUBSTITUTED OXAZOLES FOR THE TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1998-03-04 | — | — | EP | disclosed |